Stock Region Penny Picks
Good Morning, Stock Region Family!
Good Morning, Stock Region Family!
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: The following newsletter is for informational and educational purposes only. We are not financial advisors, and this is not financial advice. Trading stocks involves risk, and you should always do your own research before making any investment decisions.
The market never sleeps, and neither do we when it comes to hunting down the most interesting moves of the day. We have a packed watchlist for you today, featuring everything from private placements to massive defense contracts. Some of these updates have me seriously excited, while a couple of others have me proceeding with caution.
Let’s dive into what is moving the needle today and what you need to keep on your radar.
$KPRX – Kiora Pharmaceuticals
Kiora just entered into a Securities Purchase Agreement to issue 438,471 shares of common stock in a private placement.
My take: Private placements are a double-edged sword. On one hand, the company gets an injection of cash to fund their operations. On the other hand, dilution is never fun for current shareholders. Watch how the market absorbs these new shares before making a move.
$HCAI – Healthcare AI
This morning, the company disclosed a regulatory update tied to its Nasdaq listing compliance.
My take: Listing compliance issues always make me sweat a bit. When a company is fighting to keep its spot on the exchange, volatility usually follows. This is a “watch and wait” situation for me. Keep your risk tight if you decide to play it.
$CETX – Cemtrex Inc.
Huge news here. Their subsidiary, Invocon, just scored a Phase I Small Business Innovation Research (SBIR) contract with the Naval Sea Systems Command (NAVSEA). This award recognizes their technical chops in advanced defense electronics and modular mine warfare components.
My take: I love seeing defense contracts. Getting a nod from the Navy is a massive validation of their technology. This kind of momentum can absolutely carry a stock, so I am keeping $CETX at the top of my screen today.
$LNAI – LQR House
More defense news! Their subsidiary, BioSymetrics, entered a commercial defense-focused collaboration with a biotech partner. They are working on an advanced AI-enabled platform for chemical threat assessment.
My take: AI mixed with defense technology? That is the ultimate powerhouse combination right now. Chemical threat assessment is a highly specialized, necessary field. With initial engagements already underway, this feels like a sleeper pick with serious long-term potential.
$IRIX – Iridex Corp
Iridex just announced a brand-new partnership with EyeProGPO to expand member access to their retina laser technology.
My take: Expanding distribution and access is exactly what you want to see a growing company do. Getting their medical devices into more hands will drive revenue, making this a very solid fundamental update.
$SKIL – Skillsoft
Earnings are in. They reported $1.26 per share, which just barely missed the $1.27 estimate. However, they reported quarterly sales of $130.65 million, beating the $130.15 million estimate. The tough pill to swallow? Earnings are down 40% from this time last year.
My take: A mixed bag. A one-cent miss on earnings is barely a scratch, and beating sales expectations shows they are still moving the needle. However, that massive year-over-year drop in earnings hurts to look at. The market might punish them for the YoY decline, so tread carefully.
That is all for today’s watchlist! Keep your eyes peeled, stick to your trading plans, and do not let FOMO drive your decisions. Let’s have a great day out there in the markets.
Disclaimer: Stock trading carries a high level of risk, and you could lose some or all of your initial investment. The opinions expressed in this newsletter are solely those of the author and do not represent guaranteed outcomes. Always consult with a registered financial professional and conduct your own due diligence before investing.